Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Exited during Q4 due to intensifying competition and headwinds from its pain product, Librela, redeploying the capital into Danaher.
— Brown Advisory LLC
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Zoetis Inc.
Zoetis ($ZTS) is a global leader in animal health, engaged in the discovery, development, and manufacture of veterinary pharmaceuticals, vaccines, and diagnostic products for livestock and companion animals. The manager divested...
Zoetis Inc. ($ZTS) is the global leader in animal health, producing specialized veterinary medicines, vaccines, and diagnostic tests for companion pets and livestock. Middle Coast initiated...
Zoetis Inc. is a dominant player in the animal health industry, but its capital allocation strategy has focused on share buybacks rather than organic growth. The com...
More institutional theses from Brown Advisory Large-Cap Growth Strategy
Marvell Technology, Inc. ($MRVL) designs and develops high-performance semiconductor solutions focused on data infrastructure, including custom Application-Specific Integrated Circuits (ASICs), high-speed electro-optics, and network switching components. The stock represents...
The company exhibited broad-based operational strength across Google Cloud, Search, and YouTube, supported by AI workload demands. Healthy paid-click trends...